Telix Pharmaceuticals Launches AU$600 Million Convertible Bond Offering to Fund Theranostic Portfolio, Pursue Potential M&As
Telix Pharmaceuticals Launches AU$600 Million Convertible Bond Offering to Fund Theranostic Portfolio, Pursue Potential M&As
Telix Pharmaceuticals推出了澳元6,000萬可轉債券型發行以爲其治療性產品線提供基金，並追求可能的藥品相關併購。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊